HMOX1 and steatosis: Recently, it was found that the administration of the HO-1 inducer hemin significantly ameliorates the severity of steatosis, inflammation, and fibrosis and also decreases the serum ALT and AST levels by inhibiting the activation of canonical and noncanonical Wnt signaling pathways in MCD mice [57].